This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P170042S004 |
Classification Name | None |
Applicant | |
PMA | P170042 |
Supplement | S004 |
Supplement Number | Date | Supplement Type |
---|---|---|
P170042 | Original Filing | |
S012 | 2023-01-06 | 30-day Notice |
S011 | 2021-08-20 | Normal 180 Day Track No User Fee |
S010 | 2021-07-09 | 30-day Notice |
S009 | 2021-05-04 | 30-day Notice |
S008 | 2020-09-01 | 30-day Notice |
S007 | 2020-08-31 | 30-day Notice |
S006 | 2020-08-03 | 30-day Notice |
S005 | ||
S004 | ||
S003 | 2019-04-01 | Normal 180 Day Track No User Fee |
S002 | 2018-09-04 | Panel Track |
S001 | 2018-08-20 | Special (immediate Track) |